Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt D Furberg

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|May 23, 2007
Rosiglitazone and cardiovascular riskBruce M Psaty, Curt D Furberg
Neurology|May 7, 2008
Turning over a new leaf: Ginkgo biloba in prevention of dementia?Steven T DeKosky, Curt D Furberg
JAMA|September 6, 2012
The safety risks of innovation: the FDA's Expedited Drug Development PathwayThomas J Moore, Curt D Furberg
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 29, 2003
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose toleranceHelmut Sinzinger, Harald Kritz, Curt D Furberg
Diabetes Care|January 20, 2006
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et alBruce M Psaty, Thomas Lumley, Curt D Furberg
JAMA|September 13, 2007
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysisSonal Singh, Yoon K Loke, Curt D Furberg
Plos One|December 24, 2010
Prescription drugs associated with reports of violence towards othersThomas J Moore, Joseph Glenmullen, Curt D Furberg
The Annals of Pharmacotherapy|July 22, 2010
Thoughts and acts of aggression/violence toward others reported in association with vareniclineThomas J Moore, Joseph Glenmullen, Curt D Furberg
Diabetes Care|May 31, 2007
Thiazolidinediones and heart failure: a teleo-analysisSonal Singh, Yoon K Loke, Curt D Furberg
JAMA|July 9, 2004
Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapiesBruce M Psaty, Thomas Lumley, Curt D Furberg
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|May 23, 2007
Rosiglitazone and cardiovascular riskBruce M Psaty, Curt D Furberg
Neurology|May 7, 2008
Turning over a new leaf: Ginkgo biloba in prevention of dementia?Steven T DeKosky, Curt D Furberg
JAMA|September 6, 2012
The safety risks of innovation: the FDA's Expedited Drug Development PathwayThomas J Moore, Curt D Furberg
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 29, 2003
Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose toleranceHelmut Sinzinger, Harald Kritz, Curt D Furberg
Diabetes Care|January 20, 2006
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et alBruce M Psaty, Thomas Lumley, Curt D Furberg
JAMA|September 13, 2007
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysisSonal Singh, Yoon K Loke, Curt D Furberg
Plos One|December 24, 2010
Prescription drugs associated with reports of violence towards othersThomas J Moore, Joseph Glenmullen, Curt D Furberg
The Annals of Pharmacotherapy|July 22, 2010
Thoughts and acts of aggression/violence toward others reported in association with vareniclineThomas J Moore, Joseph Glenmullen, Curt D Furberg
Diabetes Care|May 31, 2007
Thiazolidinediones and heart failure: a teleo-analysisSonal Singh, Yoon K Loke, Curt D Furberg
JAMA|July 9, 2004
Meta-analysis of health outcomes of chlorthalidone-based vs nonchlorthalidone-based low-dose diuretic therapiesBruce M Psaty, Thomas Lumley, Curt D Furberg
Pageof 17